Edwards Lifesciences Sees Q4 Adj EPS $0.61-$0.69 vs $0.71 Est; Sees Sales $1.670B-$1.750B vs $1.700B Est
Benzinga Newsdesk 2 weeks ago
NewsGuidanceHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Edwards Lifesciences (NYSE:EW) is looking for Q4 Adj EPS of $0.61-$0.69 vs $0.71 analyst estimate. sees sales of $1.670 billion-$1.750 billion vs $1.700 billion analyst estimate.
Edwards Lifesciences (NYSE:EW) is looking for Q4 Adj EPS of $0.61-$0.69 vs $0.71 analyst estimate. sees sales of $1.670 billion-$1.750 billion vs $1.700 billion analyst estimate.
